BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 11911839)

  • 1. p53-Independent induction of Fas and apoptosis in leukemic cells by an adenosine derivative, Cl-IB-MECA.
    Kim SG; Ravi G; Hoffmann C; Jung YJ; Kim M; Chen A; Jacobson KA
    Biochem Pharmacol; 2002 Mar; 63(5):871-80. PubMed ID: 11911839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of apoptosis in rat cardiocytes by A3 adenosine receptor activation and its suppression by isoproterenol.
    Shneyvays V; Jacobson KA; Li AH; Nawrath H; Zinman T; Isaac A; Shainberg A
    Exp Cell Res; 2000 May; 257(1):111-26. PubMed ID: 10854059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel adenosine analog, thio-Cl-IB-MECA, induces G0/G1 cell cycle arrest and apoptosis in human promyelocytic leukemia HL-60 cells.
    Lee EJ; Min HY; Chung HJ; Park EJ; Shin DH; Jeong LS; Lee SK
    Biochem Pharmacol; 2005 Sep; 70(6):918-24. PubMed ID: 16051194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P-glycoprotein mediates resistance to A3 adenosine receptor agonist 2-chloro-N6-(3-iodobenzyl)-adenosine-5'-n-methyluronamide in human leukemia cells.
    Mlejnek P; Dolezel P; Kosztyu P
    J Cell Physiol; 2012 Feb; 227(2):676-85. PubMed ID: 21520073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cl-IB-MECA [2-chloro-N6-(3-iodobenzyl)adenosine-5'-N-methylcarboxamide] reduces ischemia/reperfusion injury in mice by activating the A3 adenosine receptor.
    Ge ZD; Peart JN; Kreckler LM; Wan TC; Jacobson MA; Gross GJ; Auchampach JA
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1200-10. PubMed ID: 16985166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of A(3) adenosine receptor induces calcium entry and chloride secretion in A(6) cells.
    Reshkin SJ; Guerra L; Bagorda A; Debellis L; Cardone R; Li AH; Jacobson KA; Casavola V
    J Membr Biol; 2000 Nov; 178(2):103-13. PubMed ID: 11083899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional expression of adenosine A2A and A3 receptors in the mouse dendritic cell line XS-106.
    Dickenson JM; Reeder S; Rees B; Alexander S; Kendall D
    Eur J Pharmacol; 2003 Aug; 474(1):43-51. PubMed ID: 12909194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of apoptosis by the adenosine derivative IB-MECA in parental or multidrug-resistant HL-60 leukemia cells: possible relationship to the effects on inhibitor of apoptosis protein levels.
    Notarbartolo M; Lo Cicero S; Meli M; Poma P; Labbozzetta M; Cervello M; D'Alessandro N
    Chemotherapy; 2005 Aug; 51(5):272-9. PubMed ID: 16088125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological analysis of calcium responses mediated by the human A3 adenosine receptor in monocyte-derived dendritic cells and recombinant cells.
    Fossetta J; Jackson J; Deno G; Fan X; Du XK; Bober L; Soudé-Bermejo A; de Bouteiller O; Caux C; Lunn C; Lundell D; Palmer RK
    Mol Pharmacol; 2003 Feb; 63(2):342-50. PubMed ID: 12527805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for histamine in cytokine modulation by the adenosine A(3) receptor agonist, 2-Cl-IB-MECA.
    Smith SR; Denhardt G; Terminelli C
    Eur J Pharmacol; 2002 Dec; 457(1):57-69. PubMed ID: 12460644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The adenosine A3 receptor agonist Cl-IB-MECA induces cell death through Ca²⁺/ROS-dependent down regulation of ERK and Akt in A172 human glioma cells.
    Kim TH; Kim YK; Woo JS
    Neurochem Res; 2012 Dec; 37(12):2667-77. PubMed ID: 22878643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the adenosinergic system in lung fibrosis.
    Della Latta V; Cabiati M; Rocchiccioli S; Del Ry S; Morales MA
    Pharmacol Res; 2013 Oct; 76():182-9. PubMed ID: 23994158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of synthetic A3 adenosine receptor agonists on cell proliferation and viability are receptor independent at micromolar concentrations.
    Mlejnek P; Dolezel P; Frydrych I
    J Physiol Biochem; 2013 Sep; 69(3):405-17. PubMed ID: 23184730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine A3 receptor agonists protect HL-60 and U-937 cells from apoptosis induced by A3 antagonists.
    Yao Y; Sei Y; Abbracchio MP; Jiang JL; Kim YC; Jacobson KA
    Biochem Biophys Res Commun; 1997 Mar; 232(2):317-22. PubMed ID: 9125172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of apoptosis by A3 adenosine receptor agonist N-(3-iodobenzyl)-adenosine-5'-N-methylcarboxamide in human leukaemia cells: a possible involvement of intracellular mechanism.
    Mlejnek P; Dolezel P
    Acta Physiol (Oxf); 2010 Jun; 199(2):171-9. PubMed ID: 20121715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of apoptosis in cardiac myocytes by an A3 adenosine receptor agonist.
    Shneyvays V; Nawrath H; Jacobson KA; Shainberg A
    Exp Cell Res; 1998 Sep; 243(2):383-97. PubMed ID: 9743598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Species-dependent hemodynamic effects of adenosine A3-receptor agonists IB-MECA and Cl-IB-MECA.
    Lasley RD; Narayan P; Jahania MS; Partin EL; Kraft KR; Mentzer RM
    Am J Physiol; 1999 Jun; 276(6):H2076-84. PubMed ID: 10362690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cl-IB-MECA enhances TRAIL-induced apoptosis via the modulation of NF-kappaB signalling pathway in thyroid cancer cells.
    Morello S; Sorrentino R; Porta A; Forte G; Popolo A; Petrella A; Pinto A
    J Cell Physiol; 2009 Nov; 221(2):378-86. PubMed ID: 19562684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cl-IB-MECA inhibits human thyroid cancer cell proliferation independently of A3 adenosine receptor activation.
    Morello S; Petrella A; Festa M; Popolo A; Monaco M; Vuttariello E; Chiappetta G; Parente L; Pinto A
    Cancer Biol Ther; 2008 Feb; 7(2):278-84. PubMed ID: 18059189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial and caspase pathways are involved in the induction of apoptosis by IB-MECA in ovarian cancer cell lines.
    Abedi H; Aghaei M; Panjehpour M; Hajiahmadi S
    Tumour Biol; 2014 Nov; 35(11):11027-39. PubMed ID: 25095978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.